Success Stories: Pharmaceutical Bioscience Researcher Earns NIW Approval for Advancing Drug Discovery

Client’s Testimonial:

“I would like to deeply thank you for making this possible! It wouldn’t happen without your help!”

On September 8^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Student in the Field of Pharmaceutical Bioscience (Approval Notice).

General Field: Computational Astrophysics

Position at the Time of Case Filing: PhD Student

Country of Origin: Iran

Country of Residence at the Time of Filing: Sweden

Approval Notice Date: September 8^th, 2025

Processing Time: 1 year, 7 months, 23 days

Case Summary:

Drug development remains one of the costliest and most uncertain areas of healthcare, with nearly 90% of projects failing in clinical trials. This inefficiency delays the availability of effective therapies, drives up costs, and places a heavy burden on healthcare systems and patients alike.

A pharmaceutical bioscience researcher has dedicated her career to addressing this challenge by improving the pre-clinical phase of drug research. She designs and advances in-vitro testing methodologies that enhance precision, streamline timelines, reduce costs, and minimize the need for animal testing. By making early-stage research more reliable and efficient, her work strengthens the entire drug discovery pipeline, ensuring that promising therapies are more likely to succeed in clinical development.

Her contributions have been recognized internationally, with funding support from the Swedish Research Council, the Swedish Brain Foundation, and the Novo Nordisk Foundation. She has also built a strong academic record, authoring six peer-reviewed journal articles (including one first-authored), a first-authored conference abstract, and a co-authored patent application. Her research has been cited 47 times, and she has contributed as a peer reviewer, reflecting professional recognition in her field.

Experts in pharmaceutical science have praised her impact. As one noted, “By offering a standardized approach applicable worldwide, [Client]’s research revolutionizes toxin assessment methodologies, ensuring consistency across product batches. This transformative shift not only contributes to the advancement of neurotoxin research but also promotes a globally ethical and cost-effective approach with far-reaching implications for the field.”

With this track record of innovation and recognition, her EB-2 NIW petition was approved. NAILG carefully prepared and presented the case, securing a successful outcome. With her NIW approval, she is now positioned to continue advancing drug discovery methods that will foster better healthcare outcomes, strengthen the U.S. pharmaceutical industry, and contribute to economic growth.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.